Header Logo

Connection

Mahdi Garelnabi to Inflammation

This is a "connection" page, showing publications Mahdi Garelnabi has written about Inflammation.
Connection Strength

0.899
  1. Wu T, Mazhar Z, Alsayrafi D, Garelnabi M. p-Cymene Modulate Oxidative Stress and Inflammation in Murine Macrophages: Potential Implication in Atherosclerosis. Cardiovasc Hematol Agents Med Chem. 2020; 18(2):151-157.
    View in: PubMed
    Score: 0.511
  2. Punch E, Klein J, Diaba-Nuhoho P, Morawietz H, Garelnabi M. Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis. J Am Heart Assoc. 2022 02; 11(3):e023328.
    View in: PubMed
    Score: 0.147
  3. McGrail L, Garelnabi M. Polyphenolic Compounds and Gut Microbiome in Cardiovascular Diseases. Curr Pharm Biotechnol. 2020; 21(7):578-586.
    View in: PubMed
    Score: 0.128
  4. Parthasarathy S, Litvinov D, Selvarajan K, Garelnabi M. Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta. 2008 May; 1781(5):221-31.
    View in: PubMed
    Score: 0.057
  5. Garelnabi M, Selvarajan K, Litvinov D, Santanam N, Parthasarathy S. Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms. Atherosclerosis. 2008 Aug; 199(2):304-9.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.